昌吉哪里打掉孩子医院好昌吉包茎开刀手术多少钱,昌吉取环多少钱一次大概,昌吉做无痛人流大概需多少钱,昌吉治疗包皮过长多少费用,昌吉切包皮过长切除价格,昌吉看妇科到那个好,昌吉多长时间内可以做无痛人流

SAN FRANCISCO, Dec. 13 (Xinhua) -- A Nokia executive has claimed that the youth of today are fed up with the iPhone and baffled by Android, U.S. media reported on Tuesday."What we see is that youth are pretty much fed up with iPhones. Everyone has the iPhone. Also, many are not happy with the complexity of Android and the lack of security," said Niels Munksgaard, director of portfolio, product marketing and sales at Nokia entertainment global, in an exclusive interview with technology news site Pocket-lint.He added that the youth today want to try something new and are turning to the Windows phone platform.Many tech bloggers and industry critics said Nokia, the once leader who is eager for a comeback in the mobile industry, should not trash-talk its competitors, noting that it should focus on breakthroughs like design, ecosystem of app developers to get back its place in the competition.Nokia has placed most of its bets on Windows phone platform as it introduced Lumia 800 and Lumia 710 in London in late October. It is also reportedly testing the 4G version of Lumia 800 in the United States.

BEIJING, Dec. 10 (Xinhua) -- Pharmaceutical producers will risk having their operation license revoked if they use prohibited chemicals as medicine ingredients or involved in fake drug production, China's drug regulator said in a circular Saturday.The State Food and Drug Administration said it would name and shame pharmaceutical companies if they make phoney medicine and withdraw the operation licenses of pharmacies if they intentionally sell unqualified drugs.The circular came in the wake of several counterfeit medicine scandals uncovered by Chinese police in the past few months.On Nov. 4, police seized more than 65 million imitation medicinal tablets and arrested 114 suspects in a cross-provincial raid on counterfeit drugs.In October, police raided on an illegal drug production and sale network and ended up with the seizure of 190 million yuan (29.9 million U.S. dollars) worth of counterfeit drugs.The suspects were found to have used starch or corn powder as ingredients for bogus medicine, or re-packaged expired pharmaceuticals.Police also found animal feed and chemical pigments in the counterfeit products.

WASHINGTON, Oct. 9 (Xinhua) -- U.S. researchers have found a way to block, in an animal model, the damaging inflammation that contributes to many disease conditions. In their report receiving early online publication Sunday in Nature Biotechnology, researchers describe using small interfering RNA technology to silence the biochemical signals that attract a particular group of inflammatory cells to areas of tissue damage."The white blood cells known as monocytes play a critical role in the early stages of the immune response," says Matthias Nahrendorf, of the Massachusetts General Hospital (MGH) Center for Systems Biology, the paper's senior author. "We now know there are two subsets of monocytes -- an inflammatory subset that defends against pathogens and a reparative subset that supports healing. But if the inflammatory response is excessive, it can block the healing process and exacerbate conditions such as heart disease and cancer."Cells damaged by injury or disease release a cocktail of chemicals called cytokines that attract immune cells to the site of the damage. Inflammatory monocytes are guided to sites of tissue injury by a receptor protein called CCR2, and the MGH-led team devised a strategy targeting that molecule to block the inflammatory process but not the action of the reparative monocytes.Small interfering RNA (siRNA) technology prevents production of specific proteins by binding to associated messenger RNA molecules and preventing their translation. However, the technique requires extreme precision in developing the right siRNA molecule and delivering it to the correct cellular location.To make sure that their siRNA preparation targeted the right monocytes, researchers first confirmed that its use reduced levels of CCR2 in monocytes and increased levels of the fragments produced when siRNA binds to its target. They then showed that monocytes from mice treated with the siRNA preparation were unable to migrate towards CCR2's usual molecular target. Experiments in animal models of several important diseases showed that the siRNA preparation reduced the amount of cardiac muscle damaged by a heart attack, reduced the size and the number of inflammatory cells in atherosclerotic plaques and in lymphomas, and improved the survival of transplanted pancreatic islets."These inflammatory monocytes are involved in almost every major disease," Nahrendorf explains. "Anti-inflammatory drugs currently on the market hit every inflammatory cell in the body, which can produce unwanted side effects. This new siRNA treatment doesn't affect inflammatory cells that don't rely on the CCR2 receptor. That makes a big difference."

MOSCOW, Oct. 3 (Xinhua) -- A Soyuz-2.1B rocket carried a Glonass-M navigation satellite into orbit early Monday after a two-day delay caused by high winds, a Russian Space Forces spokesman said."The launch of the booster rocket is as scheduled. The satellite Glonass-M was put into the orbit under control at 03:55 Moscow time (2355 GMT on Sunday)," said Colonel Alexei Zolotukhin.Zolotukhin told reporters that the rocket was launched at 0:15 Moscow time (2015 GMT, Sunday) from the Plesetsk Space Center in northern Russia.The Russian Space Forces said the launch was initially scheduled for Saturday but was postponed due to high winds.Glonass is the Russian equivalent of the U.S. Global Positioning System (GPS), which is designed for both military and civilian use. The system requires 24 operational and 2-3 reserve satellites in orbit to ensure global coverage.In December 2010, a malfunction of the booster resulted in a loss of three Glonass satellites.

BAGHDAD, Nov. 15 (Xinhua) -- Iraqi President Jalal Talabani told the newly-arrived Chinese ambassador Tuesday that Iraq is willing to expand cooperation and strengthen ties with China.Talabani made the statement when receiving the credential from Ni Jian, China's new ambassador to Iraq, in his presidential palace.The friendship between Iraq and China can be traced back to more than a millennium ago and endured the test of time, Talabani said.The recent years have seen increasing cooperation and exchanges between the two countries in multiple fields, bearing positive results and breakthroughs, he said.Ni Jian said that China attaches great importance to the Chinese-Iraqi relations and is willing to broaden friendly ties with Iraq on the basis of equality and mutual benefit.